Earlymarker

Early Marker develops a non-invasive blood test utilizing whole-blood genomic profiling for cancer detection. This technology aims to identify malignancies at early stages with high sensitivity and specificity. The company provides a screening solution for improved cancer surveillance.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Early Marker develops a non-invasive blood test utilizing whole-blood genomic profiling for cancer detection. This technology aims to identify malignancies at early stages with high sensitivity and specificity. The company provides a screening solution for improved cancer surveillance.